In lifecycle management, what does launching new indications involve?

Prepare for the Drug Discovery and Healthcare Systems Test. Access flashcards and multiple-choice questions with hints and explanations. Ace your exam with our comprehensive resources!

Multiple Choice

In lifecycle management, what does launching new indications involve?

Launching new indications means expanding a medicine’s approved uses to treat additional diseases or patient populations, backed by clinical data and regulatory approvals. In lifecycle management, this label expansion allows the product to reach more patients and potentially extend its market life by building on existing safety and manufacturing profiles. It differs from withdrawing a drug from the market, which ends its availability, from price cuts, which are about pricing strategy, and from limiting use to a single group, which narrows access rather than broadens it.

Launching new indications means expanding a medicine’s approved uses to treat additional diseases or patient populations, backed by clinical data and regulatory approvals. In lifecycle management, this label expansion allows the product to reach more patients and potentially extend its market life by building on existing safety and manufacturing profiles. It differs from withdrawing a drug from the market, which ends its availability, from price cuts, which are about pricing strategy, and from limiting use to a single group, which narrows access rather than broadens it.

More practice questions